Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding.

IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Clinical Medicine Insights-Endocrinology and Diabetes Pub Date : 2024-10-28 eCollection Date: 2024-01-01 DOI:10.1177/11795514241296777
Ach Taieb, Gorchane Asma, Methnani Jabeur, Ben Abdessalem Fatma, Ben Haj Slama Nassim, Ben Abdelkrim Asma
{"title":"Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding.","authors":"Ach Taieb, Gorchane Asma, Methnani Jabeur, Ben Abdessalem Fatma, Ben Haj Slama Nassim, Ben Abdelkrim Asma","doi":"10.1177/11795514241296777","DOIUrl":null,"url":null,"abstract":"<p><p>Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that affects women at various stages of life, presenting a wide range of symptoms and health implications. The term \"Polycystic Ovary Syndrome\" can be misleading, prompting many within the medical community and advocacy groups to advocate for a name change. Critics argue that this terminology can complicate understanding and awareness of the disease among patients. The primary concern is that PCOS emphasizes the ovarian aspect, fostering the misconception that PCOS is merely a gynecological disorder. In reality, PCOS impacts multiple organ systems, particularly metabolic health. Patients frequently experience insulin resistance, weight gain, irregular menstrual cycles, and hirsutism-symptoms that extend beyond ovarian dysfunction. In light of these issues, there is increasing support for renaming PCOS to better reflect its systemic implications and minimize confusion. The current name may hinder understanding and potentially lead to inadequate disease management. Alternative names have been proposed, including \"Ovarian Dysmetabolic Syndrome,\" which our team supports, as well as \"Metabolic Reproductive Syndrome\" and \"Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome.\" These alternatives aim to highlight the hormonal imbalances and metabolic disturbances associated with the condition, fostering inclusivity and reducing stigma for all affected individuals. This narrative review provides a historical overview of PCOS, tracing its recognition from early descriptions to contemporary guidelines. We discuss the evolving understanding of its pathophysiology and the rationale behind the proposed name change. By adopting a new nomenclature, we can enhance understanding among healthcare professionals, increase inclusivity for affected women, reduce the stigma and anxiety linked to the diagnosis, and offer a more accurate representation of the condition's complex pathophysiology.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"17 ","pages":"11795514241296777"},"PeriodicalIF":2.7000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528641/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine Insights-Endocrinology and Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11795514241296777","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that affects women at various stages of life, presenting a wide range of symptoms and health implications. The term "Polycystic Ovary Syndrome" can be misleading, prompting many within the medical community and advocacy groups to advocate for a name change. Critics argue that this terminology can complicate understanding and awareness of the disease among patients. The primary concern is that PCOS emphasizes the ovarian aspect, fostering the misconception that PCOS is merely a gynecological disorder. In reality, PCOS impacts multiple organ systems, particularly metabolic health. Patients frequently experience insulin resistance, weight gain, irregular menstrual cycles, and hirsutism-symptoms that extend beyond ovarian dysfunction. In light of these issues, there is increasing support for renaming PCOS to better reflect its systemic implications and minimize confusion. The current name may hinder understanding and potentially lead to inadequate disease management. Alternative names have been proposed, including "Ovarian Dysmetabolic Syndrome," which our team supports, as well as "Metabolic Reproductive Syndrome" and "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome." These alternatives aim to highlight the hormonal imbalances and metabolic disturbances associated with the condition, fostering inclusivity and reducing stigma for all affected individuals. This narrative review provides a historical overview of PCOS, tracing its recognition from early descriptions to contemporary guidelines. We discuss the evolving understanding of its pathophysiology and the rationale behind the proposed name change. By adopting a new nomenclature, we can enhance understanding among healthcare professionals, increase inclusivity for affected women, reduce the stigma and anxiety linked to the diagnosis, and offer a more accurate representation of the condition's complex pathophysiology.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重新思考术语:从重新命名多囊卵巢综合症的角度来加深病理生理学的理解。
多囊卵巢综合症(PCOS)是一种复杂的内分泌失调症,影响着处于不同生命阶段的女性,表现出各种症状并对健康产生影响。多囊卵巢综合症 "一词可能具有误导性,促使许多医学界人士和倡导团体主张更改名称。批评者认为,这一术语会使患者对该疾病的理解和认识复杂化。主要的担忧是,多囊卵巢综合症强调卵巢方面的问题,使人误以为多囊卵巢综合症仅仅是一种妇科疾病。实际上,多囊卵巢综合症会影响多个器官系统,尤其是代谢健康。患者经常会出现胰岛素抵抗、体重增加、月经周期不规律和多毛等症状,这些症状已经超出了卵巢功能障碍的范畴。鉴于这些问题,越来越多的人支持对多囊卵巢综合症重新命名,以更好地反映其系统性影响并减少混淆。目前的名称可能会妨碍人们对疾病的理解,并可能导致疾病管理不当。人们提出了一些替代名称,包括我们团队支持的 "卵巢代谢异常综合征",以及 "代谢性生殖综合征 "和 "高雄激素持续性排卵功能障碍综合征"。这些替代名称旨在强调与该病症相关的荷尔蒙失调和代谢紊乱,促进包容性,减少对所有患者的歧视。这篇叙述性综述概述了多囊卵巢综合症的历史,追溯了从早期描述到当代指南对该疾病的认识。我们讨论了对其病理生理学不断发展的理解,以及建议更名的理由。通过采用新的命名方法,我们可以加强医疗保健专业人员对该疾病的理解,增加对患病妇女的包容性,减少与该诊断相关的耻辱感和焦虑感,并更准确地反映该疾病复杂的病理生理学。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
15
审稿时长
8 weeks
期刊最新文献
Assessing the Effects of HbA1c Reduction on Alleviating Chronic Nonspecific Low Back Pain in Prediabetic Non-obese Patients: A Non-Randomized Controlled Trial. Trends of Pathological Findings in Patients with Thyroid Diseases: A Single-center, Retrospective Study. Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding. Inhibitory Effect of TCF7L2 on Pancreatic β-Cell Dedifferentiation via ERK/MAPK Signaling Pathway in Diabetes. Exploring the Impact of Social Media on Attaining HbA1c Targets in Individuals with Type 2 Diabetes Mellitus in Iraq: A Cross-Sectional Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1